Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Fish and Richardson
Merck
Cantor Fitzgerald
UBS
Deloitte
Farmers Insurance
Federal Trade Commission

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,403,858

« Back to Dashboard

Summary for Patent: 5,403,858
Title: New compositions containing taxane derivatives
Abstract:Compositions containing taxane derivatives, consist of a solution of such derivative in a surfactant consisting of polysorbate, polyethelene glycol or hydrogenated castor oil. These compositions can be used to prepare perfusion solutions essentially free of ethanol.
Inventor(s): Bastard; Jean-Pierre (Lesigny, FR), Dupechez; Thierry (Villemoisson sur Orge, FR), Fabre; Jean-Louis (Paris, FR)
Assignee: Rhone-Poulenc Rorer, S.A. (Antony, FR)
Application Number:07/930,392
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,403,858
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Formulation;

Drugs Protected by US Patent 5,403,858

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,403,858

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France91 08527Jul 8, 1991
PCT Information
PCT FiledJuly 03, 1992PCT Application Number:PCT/FR92/00624
PCT Publication Date:January 21, 1993PCT Publication Number: WO93/00928

International Family Members for US Patent 5,403,858

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 147992 ➤ Try a Free Trial
Austria 161193 ➤ Try a Free Trial
Australia 2278792 ➤ Try a Free Trial
Australia 666859 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Colorcon
Daiichi Sankyo
Federal Trade Commission
US Department of Justice
QuintilesIMS
Chinese Patent Office
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.